Center of Excellence
Structural & Valvular Heart Disease
Program Overview
The Structural & Valvular Heart Disease Center of Excellence at the NCH Rooney Heart expels expertise in the management of complex Structural and Valvular Heart Disease. As such, we offer patients first-in-class care using a multidisciplinary team approach of sub-specialty experts with access to the latest advancements to assure patients the best of care.
Valvular disease remains one of the leading causes of heart disease in America and worldwide. Exciting advancements in the field of cardiology have recently broadened the scope of how we diagnosis and treat valvular conditions, providing patients access to a multitude of innovative options and novel solutions.
Valvular disease remains one of the leading causes of heart disease in America and worldwide. Exciting advancements in the field of cardiology have recently broadened the scope of how we diagnosis and treat valvular conditions, providing patients access to a multitude of innovative options and novel solutions.
Conditions We Treat
We specialize in the diagnoses and treatment of numerous structural and valvular heart conditions including:
- Aortic Regurgitation
- Aortic Stenosis
- Arteriovenous Malformation (AVM)
- Atrial Septal Defect (ASD)
- Hypertrophic Cardiomyopathy
- Left Atrial Appendage Closure (Watchman)
- Mitral Regurgitation
- Mitral Stenosis
- Mitral Valve Prolapse
- Paravalvular Leaks
- Patent Ductus Arteriosum (PDA)
- Patent Foramen Ovale (PFO)
- Pulmonic Regurgitation
- Pulmonic Stenosis
- Rheumatic Heart Disease
- Tricuspid Regurgitation
- Tricuspid Stenosis
- Valvular Endocarditis
- Ventricular Septal Defects (VSD)
- Ventricular or Aortic Pseudo-aneurysm
Testing & Diagnostics
We offer patients access to the best cardiac imagers and the latest imaging capabilities to accurately diagnose and assure patients the highest quality of care, including but not limited to:
- 3D Transthoracic and Transesophageal Echocardiography
- Cardiac CT
- Cardiac MRI
- Intracardiac Echocardiography
- Cardiac Catheterization
- Invasive Hemodynamics with Exercise Physiology
- Cardiac PET
- Cardiac SPECT
- Stress Echo Imaging
Procedures & Treatments Offered
- Alcohol Septal Ablation
- Closure of Ventricular or Aortic Pseudo-aneurysm
- Left Atrial Appendage Closure (Watchman & Amulet)
- Minimally Invasive Aortic Valve surgery
- Minimally Invasive Mitral Valve surgery
- Mitral Valve Replacement (TMVR)
- PD & Pulmonary Arterial Venus Malformations (AVM)
- Surgical Valve Repair and Replacement (SAVR, MVR, TVR)
- Transcatheter Aortic (TAVR)
- Transcatheter Closure of ASD, PFO & VSD
- Transcatheter Closure of PDA
- Transcatheter Closure of Perivalvular Leaks
- Transcatheter Mitral Valve Edge-to-Edge Repair (TEER)
- Transcatheter Pulmonic Valvuloplasty or Replacement
- Transcatheter Tricuspid Valve Repair or Replacement (TEER & Evoque)
Clinical Research Trials
As a Center of Excellence in Structural and Valvular Heart Disease we offer patients access to the latest clinical trials and innovative treatment options. Our program has been recognized as one of the only Heart Programs in the region with access to over 40 cardiovascular clinical trials, including some in the realm of transcatheter valve therapies:
- TRISCEND II Trial (Evoque – Tricuspid Valve)
- TRISCEND CAS Registry (Evoque – Tricuspid Valve)
- CLASP TR II Trial (Pascal TEER)
- CLASP IIF (PASCAL TEER)
- ENCIRCLE Trial (Mitral Valve Replacement)
- PFO Closure (GORE)
- REPAIR MR Trial (Mitraclip vs Surgery)
- REPAIR MR Trial (Mitraclip vs Surgery)
Our Team
Our Patient-Centered Multispecialty Cardiac Team is best represented by a group of highly skilled operators and stellar clinicians from top organizations. Under the leadership of Dr. Robert J. Cubeddu, President, NCH Rooney Heart Institute, we have expanded our Center of Excellence to include expertise in transcatheter valve therapies, minimally invasive open-heart surgery, cardiovascular critical care intensivists, heart failure specialists, cardiac anesthesiology, advanced cardiac imaging and mechanical circulatory support.
Accolades
- First in the State to perform a Transcatheter Tricuspid valve replacement
- First in the region to perform a Transcatheter Mitral Valve repair
- First in the region to perform a Transcatheter Tricuspid valve repair
- First in the State to perform a Transcatheter Tricuspid valve replacement
- First in the region to perform a Transcatheter Mitral Valve repair
- First in the region to perform a Transcatheter Tricuspid valve repair
Publications
- The Mortality Burden of Untreated Aortic Stenosis
- Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study
- Structural Valve Deterioration in Transcatheter Aortic Bioprostheses: Diagnosis, Pathogenesis, and Treatment
- Successful Obliteration of a Lateral Residual Commissural Jet After MitraClip Implantation Using a Cardioform Septal Occluder
- Impact of Transcatheter Aortic Valve Replacement on Severity of Chronic Kidney Disease
- Mitral Transcatheter Edge-to-Edge Repair With the PASCAL Precision System: Device Knobology and Review of Advanced Steering Maneuvers
- Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5
- Percutaneous Techniques for Mitral Valve Disease
- Predictors and outcomes of stroke after transcatheter aortic valve replacement
- Prosthetic valve leaflet perforation resulting in critical aortic insufficiency: A rare late complication after use of Cor-knot®
- Cardioform Septal Occluder for the Closure of a Peri-Device Leak After Initial Watchman Implantation
- Percutaneous Techniques for the Treatment of Patients with Functional Mitral Valve Regurgitation
- Difference in outcome among women and men after percutaneous mitral valvuloplasty†
- Structural heart disease interventions: an emerging discipline in cardiovascular medicine
Make an Appointment
"Lorem ipsum dolor sit amet, consectetur adipiscing elit."
Patient Name 
"Lorem ipsum dolor sit amet, consectetur adipiscing elit."
Patient Name Previous
Next
